newratings.com  Mar 24  Comment 
WASHINGTON (dpa-AFX) - Novo Nordisk (NVO) said Friday that the Committee for Medicinal Products for Human Use or CHMP, under the European Medicines Agency or EMA, has issued a positive opinion, recommending an update of the label for Tresiba...
newratings.com  Mar 24  Comment 
BRUSSELS (dpa-AFX) - Novo Nordisk A/S (NVO) said that its shareholders approved the Company's statutory Annual Report 2016, The actual remuneration of the Board of Directors for 2016 and the remuneration level for 2017; the final dividend for...
Clusterstock  Mar 16  Comment 
Insulin prices have been rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment. As a result, the companies that make insulin have been under fire from the public and...
Reuters  Mar 16  Comment 
U.S. private equity firm Lone Star is closer to taking control of Portugal's Novo Banco with an offer to inject up to 1 billion euros ($1.07 billion) into the bank in return for a 75 percent stake, sources told Reuters.
Mondo Visione  Mar 16  Comment 
BM&FBOVESPA presents here the final proposals of the Regulations for the BM&FBOVESPA special corporate governance segments (Novo Mercado and Level 2) which will be put before a Closed Hearing. In the first phase, which begins today and...
Benzinga  Mar 10  Comment 
The pharmaceutical industry, rich with innovative players and shaken by impending regulatory changes, is a well-worn topic on Wall Street. Adam Feuerstein joined Benzinga’s Pre-Market Prep radio show to comment on the status of the market and...
Wall Street Journal  Mar 10  Comment 
A last-minute gate-crasher, little-known Aethel Ltd., is trying to upend Portugal’s plan to sell Novo Banco, the bank spawned from the ashes of collapsed lender Banco Espírito Santo.
Benzinga  Mar 10  Comment 
The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday, March 9, 2017. Novo Nordisk CEO Confirms M&A Aspirations, Won't Confirm GBT is Target The CEO Comments: Novo Nordisk's (NYSE: NVO) CEO Lars...

You may also be interested in articles related to Novo Nordisk A/S (NVO):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki